European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)

Cited by (1,088)

Items 401–500 of 1,088

1. Vitamin E function and requirements in relation to PUFA
   Daniel Raederstorff, Adrian Wyss, Philip C. Calder, Peter Weber, Manfred L. Eggersdorfer · 2015 · British Journal Of Nutrition
2. Depression and cardiovascular disease: The deep blue sea of women's heart
   Valentina Bucciarelli, Anna Laura Caterino, Francesco Bianco, Cristiano Giovanni Caputi, Sara Salerni, Susanna Sciomer, Silvia Maffei, Sabina Gallina · 2019 · Trends in Cardiovascular Medicine
3. Central Role of eNOS in the Maintenance of Endothelial Homeostasis
   Christian Heiß, Ana Rodriguez‐Mateos, Malte Kelm · 2014 · Antioxidants and Redox Signaling
4. Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals
   Aniruddh P. Patel, Minxian Wang, Uri Kartoun, Kenney Ng, Amit V. Khera · 2021 · Circulation
5. Promoting patient uptake and adherence in cardiac rehabilitation
   Kunal N. Karmali, Philippa A. Davies, Fiona C. Taylor, Andrew David Beswick, Nicole Martin, Shah B J Ebrahim · 2014 · Cochrane Database of Systematic Reviews
6. Effects of Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12‐Month Treatment
   Ikonomidis, Ignatios, Pavlidis, George, Thymis, John, Birba, Dionysia, Kalogeris, Aimilianos, Kousathana, Foteini, Kountouri, Aikaterini, Balampanis, Konstantinos, Parissis, John, Andreadou, Ioanna et al. · 2020 · Journal of the American Heart Association
7. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease: Data From UK Biobank
   Welsh, Claire, Celis-Morales, Carlos A., Brown, Rosemary, Mackay, Daniel F., Lewsey, James, Mark, Patrick B., Gray, Stuart R., Ferguson, Lyn D., Anderson, Jana J., Lyall, Donald M. et al. · 2019 · Circulation
8. Familial hypercholesterolaemia: A model of care for Australasia
   Gerald Francis Watts, DAVID R. SULLIVAN, Nicola Kazia Poplawski, Frank van Bockxmeer, Ian R Hamilton‐Craig, Peter Marshall Clifton, Richard Charles O’Brien, Warrick Bishop, Peter Myles George, P.J. Barter et al. · 2011 · Atherosclerosis Supplements
9. Differential Effects of E-Cigarette on Microvascular Endothelial Function, Arterial Stiffness and Oxidative Stress: A Randomized Crossover Trial
   Martin Chaumont, Benjamin De Becker, Wael Zaher, Antoine Culié, Guillaume Deprez, Christian Mélot, Florence Reyé, Pierre Van Antwerpen, Cédric Delporte, Nadia Debbas et al. · 2018 · Scientific Reports
10. ST‐Segment–Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors—How Common Are They, and What Are Their Outcomes?
    Stephen Thomas Vernon, Sean Coffey, Mario I D'Souza, Clara Kayei Chow, Jens G. Kilian, Karice K. Hyun, James A. Shaw, Mark Adams, Philip Roberts‐Thomson, David B. Brieger et al. · 2019 · Journal of the American Heart Association
11. Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment
    Anastasia Vladimirovna Poznyak, Nikolay K. Sadykhov, Andrey G. Kartuesov, Evgeny E. Borisov, Alexandra А. Melnichenko, Andrey V. Grechko, Alexander Nikolaevich Orekhov · 2022 · Frontiers in Cardiovascular Medicine
12. Exercise prescription in patients with different combinations of cardiovascular disease risk factors: a consensus statement from the EXPERT Working Group
    Hansen, Dominique, Niebauer, Josef, Cornelissen, Veronique, Barna, Olga, Neunhäuserer, Daniel, Stettler, Christoph, Tonoli, Cajsa, Greco, Eugenio, Fagard, Robert, Coninx, Karin et al. · 2018 · Sports Medicine
13. Differential effects of endurance, interval, and resistance training on telomerase activity and telomere length in a randomized, controlled study
    Werner, Christian M, Hecksteden, Anne, Morsch, Arne, Zundler, Joachim, Wegmann, Melissa, Kratzsch, Jürgen, Thiery, Joachim, Hohl, Mathias, Bittenbring, Jörg Thomas, Neumann, Frank et al. · 2019 · European Heart Journal
14. 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia
    Landmesser, Ulf, Chapman, M John, Stock, Jane K, Amarenco, Pierre, Belch, Jill J F, Borén, Jan, Farnier, Michel, Ference, Brian A, Gielen, Stephan, Graham, Ian et al. · 2018 · European Heart Journal
15. Novel methodologies for biomarker discovery in atherosclerosis
    Imo E. Hoefer, Sabine Steffens, Mika Ala‐Korpela, Magnus Bäck, Lina Badimón, Marie‐Luce Bochaton‐Piallat, Chantal M. Boulanger, Giuseppina Caligiuri, Stefanie Dimmeler, Jesús Egido et al. · 2015 · European Heart Journal
16. Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints—A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
    Børge Grønne Nordestgaard, Anne Langsted, Samia Mora, Genovefa D. Kolovou, Hannsjörg H.E. Baum, Éric Bruckert, Gerald Francis Watts, Grażyna Sypniewska, Olov Wiklund, Jan Borén et al. · 2016 · Clinical Chemistry
17. Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms
    Francesco Violi, Elsayed Z. Soliman, Pasquale Pignatelli, Daniele Pastori · 2016 · Journal of the American Heart Association
18. Physical activity in primary and secondary prevention of cardiovascular disease: Overview updated
    A. Alves, J. Viana, Suiane Cavalcante, N. L. Oliveira, J. Duarte, J. Mota, J. Oliveira, F. Ribeiro · 2016 · World Journal of Cardiology
19. Lycopene and Vascular Health
    Ioana Monica Mozos, Dana Liana Stoian, Alexandru Caraba, Clemens Malainer, Jarosław Olav Horbańczuk, Atanas G. Atanasov · 2018 · Frontiers in Pharmacology
20. KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Management of Blood Pressure in CKD
    Sandra J. Taler, Rajiv Agarwal, George L. Bakris, Joseph T. Flynn, Peter M. Nilsson, Mahboob Rahman, Paul W. Sanders, Stephen C. Textor, Matthew R. Weir, Raymond R. Townsend · 2013 · American Journal of Kidney Diseases
21. Vulnerable plaques and patients: state-of-the-art
    Tomaniak, Mariusz, Katagiri, Yuki, Modolo, Rodrigo, de Silva, Ranil, Khamis, Ramzi Y, Bourantas, Christos V, Torii, Ryo, Wentzel, Jolanda J, Gijsen, Frank J H, van Soest, Gijs et al. · 2020 · European Heart Journal
22. Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases
    Matthias Bernd Schulze, Anne Marie Minihane, Rasha N.M. Saleh, Ulf Risérus · 2020 · The Lancet Diabetes & Endocrinology
23. Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society
    Frederikus Albertus Klok, Walter Ageno, Cihan Ay, Magnus Bäck, Stefano Barco, Laurent Bertoletti, Cecilia Becattini, Jørn Carlsen, Marion Delcroix, Nick van Es et al. · 2021 · European Heart Journal
24. Phytosterols, Cholesterol Control, and Cardiovascular Disease
    Andrea Poli, Franca Marangoni, Alberto Corsini, Enzo Manzato, Walter Marrocco, Daniela Martini, Gerardo Medea, Francesco Visioli · 2021 · Nutrients
25. Retracted: Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial
    Ramón Estruch, Miguel Ángel Martínez‐González, Dolores Corella, Jordi Salas‐Salvadó, Montserrat Fitó, Gemma Chiva‐Blanch, Miquel Fiol, Enrique Gómez‐Gracia, Fernando Arós, José Lapetra et al. · 2016 · The Lancet Diabetes & Endocrinology · Retracted
26. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions
    Kornelia Kotseva, Dirk De Bacquer, Guy De Backer, Lars Rydén, Catriona Sian Jennings, Viveca Gyberg, Ana Abreu, Carlos Aguíar, Almudena Castro Conde, Kairat Davletov et al. · 2016 · European Journal of Preventive Cardiology
27. Prevalencia de enfermedad renal crónica en España: impacto de la acumulación de factores de riesgo cardiovascular
    Manuel Gorostidi, Mercedes Sánchez-Martínez, Luis Miguel Ruilope, Auxiliadora Graciani, Juan J. de la Cruz, Rafael Santamaría, María Dolores del Pino y Pino, Pilar Guallar‐Castillón, Fernando de Álvaro, Fernando Rodríguez‐Artalejo et al. · 2018 · Nefrología
28. Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: a nationwide population-based cohort study
    Si Hyoung Kim, Yun Kyung Cho, Ye‐Jee Kim, Chang Hee Jung, Woo Je Lee, Joong‐Yeol Park, Ji Hye Huh, Jun Goo Kang, Seong Jin Lee, Sung‐Hee Ihm · 2022 · Cardiovascular Diabetology
29. Erectile dysfunction in the cardiovascular patient
    C Vlachopoulos, Gordon S. Jackson, Christodoulos Stefanadis, P. Montorsi · 2013 · European Heart Journal
30. Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
    Fruchart, Jean-Charles · 2013 · Cardiovascular Diabetology
31. A review of telerehabilitation for cardiac patients
    Ines Frederix, Luc Vanhees, Paul Dendale, Kaatje Goetschalckx · 2014 · Journal of Telemedicine and Telecare
32. 2018 Guidelines for the Management of Dyslipidemia in Korea
    Eun‐Jung Rhee, Hyeon Chang Kim, Jae Hyeon Kim, Eun Young Lee, Byung Jin Kim, Eun Mi Kim, YoonJu Song, Jeong Hyun Lim, Byung Jin Kim, Seonghoon Choi et al. · 2019 · Journal of Lipid and Atherosclerosis
33. Effectiveness of Cognitive Behavioral Therapy for Depression and Anxiety in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis
    Reavell, James, Hopkinson, Michael, Clarkesmith, Danielle, Lane, Deirdre A. · 2018 · Psychosomatic Medicine
34. Distinct child-to-adult body mass index trajectories are associated with different levels of adult cardiometabolic risk
    Marie‐Jeanne Buscot, Russell J. Thomson, Markus Juonala, Matthew A. Sabin, David Paul Burgner, Terho J. Lehtimäki, Nina Hutri‐Kähönen, Jorma S.A. Viikari, Olli Tuomas Raitakari, Costan G. Magnussen · 2018 · European Heart Journal
35. Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview
    Simona Marchisello, Antonino Di Pino, Roberto Scicali, Francesca Urbano, Salvatore Piro, Francesco Purrello, Agata Maria Rabuazzo · 2019 · International Journal of Molecular Sciences
36. Treatment of coronary microvascular dysfunction
    C. Noel Bairey Merz, Carl J. Pepine, Hiroaki Shimokawa, Colin Berry · 2020 · Cardiovascular Research
37. State of the Science in Women's Cardiovascular Disease: A Canadian Perspective on the Influence of Sex and Gender
    Colleen M. Norris, Cindy Ying Yin Yip, Kara A. Nerenberg, Marie-Annick A Clavel, Christine Pacheco, Heather J.A. Foulds, Marsha Hardy, Christine A. Gonsalves, Shahin Jaffer, Monica J. E. Parry et al. · 2020 · Journal of the American Heart Association
38. Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths
    Ruuth, Maija, Nguyen, Su Duy, Vihervaara, Terhi, Hilvo, Mika, Laajala, Teemu D, Kondadi, Pradeep Kumar, Gisterå, Anton, Lähteenmäki, Hanna, Kittilä, Tiia, Huusko, Jenni et al. · 2018 · European Heart Journal
39. Rationale and Methods of the Study on Nutrition and Cardiovascular Risk in Spain (ENRICA)
    Fernando Rodríguez‐Artalejo, Auxiliadora Graciani, Pilar Guallar‐Castillón, Luz María León-Muñoz, M. Clemencia Zuluaga, Esther López‐García, Juan Luis Gutiérrez-Fisac, José M. Taboada, María Teresa Aguilera, Enrique Regidor et al. · 2011 · Revista Española de Cardiología (English Edition)
40. Comparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian population
    Sharmini Selvarajah, Gurpreet Kaur, Jamaiyah Haniff, Chee Cheong Kee, Guat Hiong Tee, Yolanda van der Graaf, Michiel L. Bots · 2014 · International Journal of Cardiology
41. Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial
    Michel Farnier, Peter J.H. Jones, Randall Severance, Maurizio Rocco Averna, Elisabeth Steinhagen‐Thiessen, Helen Martina Colhoun, Yunling E. Du, Corinne Hanotin, Stephen Donahue · 2015 · Atherosclerosis
42. Exercise training-induced modification in autonomic nervous system: An update for cardiac patients
    Florent Besnier, M. Labrunée, Atul Pathak, Anne Pavy‐Le Traon, Céline Galès, Jean‐Michel Sénard, Thibaut Guiraud · 2016 · Annals of Physical and Rehabilitation Medicine
43. Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway
    Marco Proietti, Giulio Francesco Romiti, Brian Olshansky, Deirdre A. Lane, Gregory Y.H. Lip · 2018 · The American Journal of Medicine
44. Standardization and quality improvement of secondary prevention through cardiovascular rehabilitation programmes in Europe: The avenue towards EAPC accreditation programme: A position statement of the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology (EAPC)
    Ana Abreu, Ines Frederix, Paul Dendale, Arne Janssen, Patrick Doherty, Massimo Francesco Piepoli, Heinz Völler, Constantinos H. Davos, the Secondary Prevention and Rehabilitation Section of EAPC Reviewers:, Marco Ambrosetti · 2020 · European Journal of Preventive Cardiology
45. Depression as a Risk Factor for the Initial Presentation of Twelve Cardiac, Cerebrovascular, and Peripheral Arterial Diseases: Data Linkage Study of 1.9 Million Women and Men
    Marina Daskalopoulou, Julie George, Kate R Walters, David Osborn, George David Batty, Dimitris Stogiannis, Eleni Rapsomaniki, Mar Pujades‐Rodríguez, Spiros Denaxas, Ruzan Udumyan et al. · 2016 · PLoS ONE
46. Plasma long non-coding RNA, CoroMarker, a novel biomarker for diagnosis of coronary artery disease
    Yujia Yang, Yue Cai, Gengze Wu, Xinjian Chen, Yukai Liu, Xinquan Wang, Junyi Yu, Chuanwei Li, Xiongwen Chen, Pedro A. José et al. · 2015 · Clinical Science
47. Phytosterols in the Treatment of Hypercholesterolemia and Prevention of Cardiovascular Diseases
    Carlos Eduardo Lassance Cabral, Márcia Regina Simas Torres Klein · 2017 · Arquivos Brasileiros de Cardiologia
48. No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY phase 3 studies
    Colhoun, Helen M., Ginsberg, Henry N., Robinson, Jennifer G., Leiter, Lawrence A., Müller-Wieland, Dirk, Henry, Robert R., Cariou, Bertrand, Baccara-Dinet, Marie T., Pordy, Robert, Merlet, Laurence et al. · 2016 · European Heart Journal
49. Early origins of adult disease: Low birth weight and vascular remodeling
    Silvia Visentin, Francesca Grumolato, Giovanni Battista Nardelli, Barbara Di Camillo, Enrico Grisan, Erich Cosmi · 2014 · Atherosclerosis
50. Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence
    Arrigo F.G. Cicero, Alessandro Colletti, Stefano Bellentani · 2018 · Nutrients
51. Magnesium and the Risk of Cardiovascular Events: A Meta-Analysis of Prospective Cohort Studies
    Xinhua Qu, Fangchun Jin, Yongqiang Hao, Huiwu Li, Tingting Tang, Hao Wang, Weili Yan, Kerong Dai · 2013 · PLoS ONE
52. Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline
    Joanne L. Ryan, Elsdon Storey, Anne M. Murray, Robyn L. Woods, Rory S Wolfe, Christopher Michael Reid, Mark Raymond Nelson, Trevor T.‐J. Chong, Jeff D. Williamson, Stephanie Alison Ward et al. · 2020 · Neurology
53. Epidemiología del síndrome coronario agudo en España: estimación del número de casos y la tendencia de 2005 a 2049
    Irene Roman Degano, Roberto Elosúa, Jaume Marrugat · 2013 · Revista Española de Cardiología
54. European Resuscitation Council Guidelines for Resuscitation 2015 Section 8. Initial management of acute coronary syndromes
    Nikolaos I Nikolaou, Hans-Richard Arntz, Abdelouahab Bellou, Farzin Beygui, Leo L Bossaert, Alain Cariou, Nicolas Danchin · 2015 · Resuscitation
55. Managing tobacco use: the neglected cardiovascular disease risk factor
    Nancy A. Rigotti, Carole Clair · 2013 · European Heart Journal
56. Imaging residual inflammatory cardiovascular risk
    Charalambos A. Antoniades, Alexios S. Antonopoulos, John Eric Deanfield · 2019 · European Heart Journal
57. Acute coronary syndromes in young patients: Presentation, treatment and outcome
    Andreas Wolfgang Schoenenberger, Dragana Radovanović, Jean‐Christophe Stauffer, Stephan Windecker, Philip M. Urban, Gregor Niedermaier, Pierre‐Frédéric Keller, Félix Gutzwiller, Paul Erné · 2009 · International Journal of Cardiology
58. Fish oil omega-3 polyunsaturated fatty acids attenuate oxidative stress-induced DNA damage in vascular endothelial cells
    Chiemi Sakai, Mari Ishida, Hideo Ohba, Hiromitsu Yamashita, Hitomi Uchida, Masao Yoshizumi, Takafumi Ishida · 2017 · PLoS ONE
59. BACPR scientific statement: British standards and core components for cardiovascular disease prevention and rehabilitation
    John Buckley, Gill Furze, Patrick Doherty, Linda Speck, Susan B. Connolly, Sally Hinton, Jennifer L. Jones, on behalf of BACPR · 2013 · Heart
60. Cocoa flavanol intake improves endothelial function and Framingham Risk Score in healthy men and women: a randomised, controlled, double-masked trial: the Flaviola Health Study
    Roberto Sansone, Ana Rodriguez‐Mateos, Jan Heuel, David Falk, Dominik Schuler, Rabea Wagstaff, Gunter Kuhnle, Jeremy P.E. Spencer, Hagen Schroeter, Marc W. Merx et al. · 2015 · British Journal Of Nutrition
61. European guidelines on chronic mesenteric ischaemia – joint United European Gastroenterology, European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Gastrointestinal and Abdominal Radiology, Netherlands Association of Hepatogastroenterologists, Hellenic Society of Gastroenterology, Cardiovascular and Interventional Radiological Society of Europe, and Dutch Mesenteric Ischemia Study group clinical guidelines on the diagnosis and treatment of patients with chronic mesenteric ischaemia
    Luke G. Terlouw, Adriaan D. Moelker, Jan Abrahamsen, Stefan Acosta, Olaf J. Bakker, Iris Baumgärtner, L. Boyer, Olivier Corcos, Louisa J. D. van Dijk, Mansur Duran et al. · 2020 · United European Gastroenterology Journal
62. Platelet activation and prothrombotic mediators at the nexus of inflammation and atherosclerosis: Potential role of antiplatelet agents
    Ronan Lordan, Αλέξανδρος Τσούπρας, Ioannis Zabetakis · 2020 · Blood Reviews
63. Fifty Plus in Ireland 2011: First Results from The Irish Longitudinal Study on Ageing
    Alan M. Barrett, George M. Savva, Virpi Timonen, Rose Anne Kenny · 2011
64. I Diretriz Brasileira de Prevenção Cardiovascular
    AF Simão, DB Précoma, JP Andrade, H Correa Filho, JFK Saraiva, GMM Oliveira, ALB Murro, A Campos, Alexandre Alessi, Álvaro Avezum et al. · 2013 · Arquivos Brasileiros de Cardiologia
65. CORonary Diet Intervention with Olive oil and cardiovascular PREVention study (the CORDIOPREV study): Rationale, methods, and baseline characteristics
    Javier Delgado‐Lista, Pablo Pérez‐Martínez, Antonio García‐Ríos, Juan Francisco Alcala-Diaz, Ana Isabel Pérez-Caballero, Francisco Gómez-Delgado, Francisco J. Fuentes, Gracia M. Quintana‐Navarro, Fernando Lopez‐Segura, Ana M. Ortiz-Morales et al. · 2016 · American Heart Journal
66. Are cardiovascular risk factors also associated with the incidence of atrial fibrillation?
    Victoria Allan, Shohreh Honarbakhsh, Juan Pablo Casas, Joshua Wallace, Ross Jacob Hunter, RICHARD JOHN SCHILLING, Pablo Perel, Katherine I. Morley, Amitava Banerjee, Harry Hemingway · 2017 · Thrombosis and Haemostasis
67. Significance of psychosocial factors in cardiology: update 2018: Position paper of the German Cardiac Society
    Albus, Christian, Waller, Christiane, Fritzsche, Kurt, Gunold, Hilka, Haass, Markus, Hamann, Bettina, Kindermann, Ingrid, Köllner, Volker, Leithäuser, Boris, Marx, Nikolaus et al. · 2019 · Clinical Research in Cardiology
68. Low LDL cholesterol,<i>PCSK9</i>and<i>HMGCR</i>genetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study
    Benn, Marianne, Nordestgaard, Børge G, Frikke-Schmidt, Ruth, Tybjærg-Hansen, Anne · 2017 · BMJ
69. ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension
    Ekkehard Grünig, Christina A. Eichstaedt, Joan Albert Barberà, Nicola Benjamin, Isabel Blanco, Eduardo Bossone, Antonio Cittadini, Gerry Coghlan, Paul A. Corris, Michele D’Alto et al. · 2018 · European Respiratory Journal
70. Efficacy and safety of aspirin for primary prevention of cardiovascular events: a meta-analysis and trial sequential analysis of randomized controlled trials
    Ahmed N Mahmoud, Mohamed M. Gad, Akram Y. Elgendy, Islam Y. Elgendy, Anthony A. Bavry · 2018 · European Heart Journal
71. Cardiovascular risk estimation in older persons: SCORE O.P
    Cooney, Marie Therese, Selmer, Randi, Lindman, Anja, Tverdal, Aage, Menotti, Alessandro, Thomsen, Troels, DeBacker, Guy, De Bacquer, Dirk, Tell, Grethe S, Njolstad, Inger et al. · 2016 · European Journal of Preventive Cardiology
72. Chemical and nutritional characteristics of brown seaweed lipids: A review
    Kazuo Miyashita, Nana Mikami, Masashi Hosokawa · 2013 · Journal of Functional Foods
73. Dietary patterns and CVD: a systematic review and meta-analysis of observational studies
    Míriam Rodríguez‐Monforte, Gemma Flores‐Mateo, Emília Sánchez · 2015 · British Journal Of Nutrition
74. A review of biosensor technologies for blood biomarkers toward monitoring cardiovascular diseases at the point-of-care
    Mengxing Ouyang, Dandan Tu, Lin Tong, Mehenur Sarwar, Arvind Bhimaraj, Chen-Zhong Li, Gerard L. Coté, Dino Di Carlo · 2020 · Biosensors and Bioelectronics
75. Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy
    Pierandrea Vinci, Emiliano Panizon, Letizia Maria Tosoni, Carla Cerrato, Federica Pellicori, Filippo Mearelli, Chiara Biasinutto, Nicola Fiotti, Filippo Giorgio Di Girolamo, Gianni Biolo · 2021 · International Journal of Molecular Sciences
76. Addition of motivational interventions to exercise and traditional Physiotherapy: a review and meta-analysis
    McGrane, N., Galvin, R., Cusack, T., Stokes, E. · 2015 · Physiotherapy
77. Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis
    Toby Pillinger, Katherine Beck, Brendon Stubbs, Oliver David Howes · 2017 · The British Journal of Psychiatry
78. The rise and fall of aspirin in the primary prevention of cardiovascular disease
    Inbar Raber, Cian P. McCarthy, Muthiah Vaduganathan, Deepak L. Bhatt, David A. Wood, John G.F. Cleland, Roger Scott Blumenthal, John William McEvoy · 2019 · The Lancet
79. Dietary fats and cardiovascular disease: Putting together the pieces of a complicated puzzle
    George Michas, Renata Micha, Antonis Zampelas · 2014 · Atherosclerosis
80. Atherosclerotic cardiovascular disease: a review of initiators and protective factors
    Mohammed S. Ellulu, Ismail Patimah, Huzwah Khaza’ai, Asmah Bt Rahmat, Yehia Awad Abed, Faisal Ali · 2016 · Inflammopharmacology
81. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries
    Kornelia Kotseva, Guy De Backer, Dirk De Bacquer, Lars Rydén, Arno Wilhelmus Hoes, Diederick E. Grobbee, Aldo Pietro Maggioni, Pedro Manuel Marques-Vidal, Catriona Sian Jennings, Ana Abreu et al. · 2020 · European Journal of Preventive Cardiology
82. Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters
    Juliane Neubronner, Jan Philipp Schuchardt, Gaby Kressel, Martin Merkel, Clemens von Schacky, Andreas Hahn · 2010 · European Journal of Clinical Nutrition
83. Cardiovascular disease in systemic lupus erythematosus: A comprehensive update
    Mayra Giannelou, Clio P. Mavragani · 2017 · Journal of Autoimmunity
84. Dysfunctional Vascular Endothelium as a Driver of Atherosclerosis: Emerging Insights Into Pathogenesis and Treatment
    Steven R. Botts, Jason E. Fish, Kathryn L. Howe · 2021 · Frontiers in Pharmacology
85. Systematic comparison of family history and polygenic risk across 24 common diseases
    Nina Mars, Joni Valdemar Lindbohm, Pietro Della Briotta Parolo, Elisabeth Widén, Jaakko A. Kaprio, Aarno V. Palotie, FinnGen, Samuli Ripatti · 2022 · The American Journal of Human Genetics
86. A Cluster-Randomized, Controlled Trial of a Simplified Multifaceted Management Program for Individuals at High Cardiovascular Risk (SimCard Trial) in Rural Tibet, China, and Haryana, India
    Tian, Maoyi, Ajay, Vamadevan S., Dunzhu, Danzeng, Hameed, Safraj S., Li, Xian, Liu, Zhong, Li, Cong, Chen, Hao, Cho, KaWing, Li, Ruilai et al. · 2015 · Circulation
87. Residual macrovascular risk in 2013: what have we learned?
    for the Residual Risk Reduction Initiative (R3i), Jean‐Charles Fruchart, Jean Davignon, Michel Paul Hermans, Khalid A Al-Rubeaan, Pierre Amarenco, Gerd Assmann, Philip J. Barter, John D. Betteridge, Éric Bruckert et al. · 2014 · Cardiovascular Diabetology
88. Cardiovascular Disease and Frailty: What Are the Mechanistic Links?
    Ralph Stewart · 2018 · Clinical Chemistry
89. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up
    The Task Force for the management of COVID-19 of the European Society of Cardiology, Colin Baigent, Stephan Windecker, Daniele Andreini, Elena Arbelo, Emanuele Barbato, Antonio Luca Bartorelli, Andreas Baumbach, Elijah Raphael Behr, Sérgio Luis Berti et al. · 2021 · European Heart Journal
90. Trends in Noncardiovascular Comorbidities Among Patients Hospitalized for Heart Failure
    Abhinav Sharma, Xin Zhao, Bradley G. Hammill, Adrian F. Hernandez, Gregg C. Fonarow, Gary Michael Felker, Clyde W. Yancy, Paul A. Heidenreich, Justin Adrian Ezekowitz, Adam D. DeVore · 2018 · Circulation Heart Failure
91. Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
    Xiaodong Zhou, Jingjing Cai, Giovanni Targher, Christopher D. Byrne, Michael David Shapiro, Ki‐Chul Sung, Virend Kristen Somers, C. Anwar A. Chahal, Jacob George, Lili Chen et al. · 2022 · Cardiovascular Diabetology
92. Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease
    Nina Chetty Raju, Magdalena Sobieraj‐Teague, Jack Hirsh, Martin James O'Donnell, John W. Eikelboom · 2011 · The American Journal of Medicine
93. A Systematic Review of the Efficacy of Bioactive Compounds in Cardiovascular Disease: Phenolic Compounds
    Óscar Daniel Rangel-Huerta, Belén Pastor‐Villaescusa, Concepción María Aguilera, Ángel Gil · 2015 · Nutrients
94. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease
    Andreas Tomaschitz, Eberhard Ritz, Burkert Mathias Pieske, Jutta Rus-Machan, Katharina Kienreich, Nicolas Verheyen, Martin Gaksch, Martin Robert Grübler, Astrid Fahrleitner‐Pammer, Peter Mrak et al. · 2013 · Metabolism
95. Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia
    Hayato Tada, Masa‐aki Kawashiri, Atsushi Nohara, Akihiro Inazu, Hiroshi Mabuchi, Masakazu Yamagishi · 2017 · European Heart Journal
96. RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020
    SV Madhu, Rajeev Chawla, B. M. Makkar, Sujoy Kumar Ghosh, Banshi Saboo, Sanjay Kalra · 2020 · Indian Journal of Endocrinology and Metabolism
97. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)
    F. Piepoli, Massimo · 2017 · International Journal of Behavioral Medicine
98. Aspirin Therapy in Primary Cardiovascular Disease Prevention
    Sigrun Halvorsen, Felicita Andreotti, Jurriën M. ten Berg, Marco Cattaneo, SERGIO COCCHERI, Roberto Marchioli, João Morais, Freek W.A. Verheugt, Raffaele De Caterina · 2014 · Journal of the American College of Cardiology
99. Challenges in secondary prevention after acute myocardial infarction: A call for action
    Massimo Francesco Piepoli, Ugo Corrà, Paul Dendale, Ines Frederix, Eva Prescott, Jean Paul Schmid, Margaret Cupples, Christi Deaton, Patrick Doherty, Pantaleo Giannuzzi et al. · 2016 · European Journal of Preventive Cardiology
100. Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France
     Philippe Giral, Anke Neumann, Alain Weill, Joël Coste · 2019 · European Heart Journal